Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3F., NO. 607, Ruiguang Rd., Neihu Dist., Taipei City, , 11492, TW
Gilead will supply enough lenacapavir doses to reach up to two million people over three years in countries supported by the Global Fund, at no profit to Gilead.
By: Charlie Sternberg
Kulkarni will lead the strategic direction and operations of ACG’s engineering division.
The company expands its portfolio with Stoboclo and Osenvelt (denosumab-bmwo).
By: Rachel Klemovitch
FF-10832’s novel formulation is designed to enhance anti-tumor activity by prolonging plasma half-life and improving targeted delivery to tumors.
The addition of 62,000 square meters of new development in 2026 will more than double the total footprint of the site to 108,000 square meters.
The U.S. launch of Conexxence and Bomyntra follows the FDA’s approval in March 2025.
The companies have released the first batch of Novalgen’s next-generation T-cell engager for first in-human clinical trials.
Agreement to support future studies investigating the combination of ateganosine and atezolizumab for safe and effective cancer treatments.
Collaboration aims to commercialize a proposed biosimilar of dupilumab across Latin America.
GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered at home.
An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.
Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1.
This adds to BioDlink's portfolio of international GMP approvals, following recent certifications in Brazil, Indonesia, Egypt, and Colombia.
Agrees to acquire two biologics manufacturing facilities from Agenus Inc. in California.
How the effectiveness, flexibility and sustainability of single-use technologies solve many of today’s challenges in biomanufacturing.
By: Chris Chen
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !